Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/09/2010CA2411922C Composition for pain mediation and apparatus and method of use thereof
03/09/2010CA2407972C Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
03/09/2010CA2399813C Indol-3-yl derivatives
03/09/2010CA2389476C Treatment of dyskinesia with a h3-histamine receptor agonist
03/09/2010CA2388395C Compound
03/09/2010CA2379282C Amido spiropiperidines promote the release of growth hormone
03/09/2010CA2349696C Controlled release formulation for water soluble drugs
03/09/2010CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators
03/09/2010CA2312842C Taurine derivatives useable in the treatment of ophthalmic disorders
03/09/2010CA2311606C Use of purified sdg as a hypotensive (vasodilator) agent
03/09/2010CA2306313C Dipeptide nitriles
03/09/2010CA2301616C Dermatological compositions comprising microbial proliferation inhibitors
03/09/2010CA2228847C Ibogamine congeners
03/09/2010CA2172153C Regulation of bcl-2 gene expression
03/09/2010CA2140598C Prolineamide derivatives
03/05/2010CA2654756A1 Vaccination for lawsonia intracellularis
03/05/2010CA2639336A1 Therapeutic combinations and methods for cardiovascular improvement and treating cardiovascular disease
03/04/2010WO2010025459A2 Novel anti-arrhythmia agent
03/04/2010WO2010025448A2 Inhibition of cell proliferation
03/04/2010WO2010025436A2 Nitrogen and sulfur-containing heterocycle derivatives
03/04/2010WO2010025416A1 Cxcr4 antagonists for kidney injury
03/04/2010WO2010025407A1 Substituted triazolo-pyridazine derivatives
03/04/2010WO2010025406A1 Stent coatings for reducing late stent thrombosis
03/04/2010WO2010025375A1 Compositions and methods of treating amyloid disease
03/04/2010WO2010025370A2 Preparation of ranolazine
03/04/2010WO2010025368A1 Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
03/04/2010WO2010025341A2 Determining age ranges of skin samples
03/04/2010WO2010025337A1 Method of treating ras associated cancer
03/04/2010WO2010025328A1 Compositions and methods of treatment comprising ceftaroline
03/04/2010WO2010025316A1 Composition and methods for relief of neuropathological pain
03/04/2010WO2010025314A2 Prevention and treatment of itch with cysteine protease inhibition
03/04/2010WO2010025308A2 Inhibitors of dutpase
03/04/2010WO2010025295A2 Compounds that modulate intracellular calcium
03/04/2010WO2010025272A1 Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
03/04/2010WO2010025266A1 Inhibitors of phosphodiesterase type 5a for treating or preventing muscle disease or the symptoms thereof in a patient
03/04/2010WO2010025251A2 Materials and methods for modulating appetite, weight gain and adhd using varenicline
03/04/2010WO2010025236A1 Composition and method for treating colds
03/04/2010WO2010025235A1 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same
03/04/2010WO2010025202A1 PYRIDO[3,2-d]PYRIDAZINE-2(1H)-ONE COMPOUNDS AS P38 MODULATORS AND METHODS OF USE THEREOF
03/04/2010WO2010025201A1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases.
03/04/2010WO2010025179A1 1-(4-ureidobenzoyl)piperazine derivatives
03/04/2010WO2010025142A1 Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
03/04/2010WO2010025138A2 Pyrimidine compounds
03/04/2010WO2010025135A2 Trimeprazine and ethopropazine derivatives for promoting bone growth
03/04/2010WO2010025073A1 Dihydroimidazo [ 1, 5-f] pteridines as polo-like kinase inhibitors
03/04/2010WO2010025043A1 Use of soluble epoxide hydrolase inhibitors in the treatment of inflammatory vascular diseases
03/04/2010WO2010025011A1 Formulations of canfosfamide and their preparation
03/04/2010WO2010024998A1 Nutritional compositions for athletes
03/04/2010WO2010024980A1 4'-amino cyclic compounds having 5-ht6 receptor affinity
03/04/2010WO2010024956A2 Antihistamine and antihistamine-like nasal application, products, and method
03/04/2010WO2010024930A2 Cortistatin analogues and syntheses therof
03/04/2010WO2010024911A1 Methods for increasing neurogenesis
03/04/2010WO2010024908A1 Methods for treatment of multiple sclerosis
03/04/2010WO2010024903A1 BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS
03/04/2010WO2010024783A1 Biarylrhodanine and pyridylrhodanine compounds and their use
03/04/2010WO2010024775A1 New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis
03/04/2010WO2010024769A1 New benzofurans suitable as precursors to compounds that are useful for imaging amyloid deposits
03/04/2010WO2010024717A1 Ligand with a broad spectrum of pharmacological activity, a pharmaceutical composition, a medicinal agent and a method of treatment
03/04/2010WO2010024676A1 Delivery of a cd40 agonist to a tumor draining lymph node of a subject
03/04/2010WO2010024549A2 Bone filler containing a sustained-release therapeutic agent for osteoporosis
03/04/2010WO2010024451A1 Pyrrole compounds
03/04/2010WO2010024430A1 2,4-diaminopyrimidine compound
03/04/2010WO2010024405A1 Ifn type-1 production inhibitor and method for searching for same
03/04/2010WO2010024396A1 NOVEL EPIGALLOCATECHIN GALLATE TRIMER, AND α-GLUCOSIDASE INHIBITOR COMPRISING EPIGALLOCATECHIN GALLATE POLYMER
03/04/2010WO2010024393A1 Novel epigallocatechin gallate tetramer, and vascular endothelial function improver comprising same
03/04/2010WO2010024384A1 Anti-hepatitis c virus composition
03/04/2010WO2010024356A1 Novel hydroxamic acid derivative having naphthyridine-n-oxide
03/04/2010WO2010024306A1 Method for treating irritable bowel syndrome
03/04/2010WO2010024298A1 Potassium channel regulator
03/04/2010WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity
03/04/2010WO2010024227A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent
03/04/2010WO2010024226A1 Prophylactic or therapeutic agent for bone/joint diseases comprising, as active ingredient, pyrrole derivative having ureide group, aminocarbonyl group and substituted phenyl group as substituents
03/04/2010WO2010024225A1 Novel dihydrotriazine derivative
03/04/2010WO2010024138A1 Glucosyltransferase inhibitor comprising epigallocatechin gallate polymer as active ingredient
03/04/2010WO2010024110A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative
03/04/2010WO2010023946A1 Novel uracil compound having nitrogenated heterocyclic ring or salt thereof
03/04/2010WO2010023931A1 1-adamantylazetidin-2-one derivative and pharmaceutical preparation comprising same
03/04/2010WO2010023917A1 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
03/04/2010WO2010023908A1 Nanocapsules containing indomethacin and manufacturing method therefor
03/04/2010WO2010023874A1 Film preparation containing loperamide hydrochloride
03/04/2010WO2010023866A1 Syngr4 for target genes of cancer therapy and diagnosis
03/04/2010WO2010023854A1 Cancer related gene, lgn/gpsm2
03/04/2010WO2010023837A1 Breast cancer related gene rqcd1
03/04/2010WO2010023742A1 Method of producing cariostatic composition
03/04/2010WO2010023725A1 Novel compound signamycin, method for production thereof, and use thereof
03/04/2010WO2010023705A1 Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders
03/04/2010WO2010023689A2 Microparticles
03/04/2010WO2010023658A2 Compositions and methods for the treatment of glioblastoma
03/04/2010WO2010023609A1 Oxazole, oxadiazole and thiazole derivatives as diacylglycerol acyltranferase inhibitors
03/04/2010WO2010023594A1 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
03/04/2010WO2010023512A1 Novel vanilloid receptor modulators, process for their preparation and pharmaceutical compositions containing them
03/04/2010WO2010023505A1 Coated particles of n-acetyl-3-mercaptoalanine with sweeteners
03/04/2010WO2010023498A1 Methods of enhancing adjuvanticity of vaccine compositions
03/04/2010WO2010023480A1 Saturated bicyclic heterocyclic derivatives as smo antagonists
03/04/2010WO2010023474A1 Novel polymorphs of sunitinib and processes for their preparation
03/04/2010WO2010023473A2 Novel crystalline form and processes for its preparation
03/04/2010WO2010023457A1 Nucleoside analogues useful as positron emission tomography (pet) imaging agents
03/04/2010WO2010023448A1 Novel potassium channel blockers
03/04/2010WO2010023446A1 Novel potassium channel blockers
03/04/2010WO2010023445A1 Novel potassium channel blocker
1 ... 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 ... 7860